1 Sponsored by Roche Diagnostics

Transcription

1 1 Sponsored by Roche Diagnostics

2 SECRETARIAT Ms Trish Cohen ADIPS Secretariat 32 St. Georges Road Toorak Vic 3142 Ph Fax adips.pc@bigpond.net.au PRESIDENT Dr Chris Nolan The Canberra Hospital Garran, ACT Ph (02) Fax (02) christopher.nolan@anu.edu.au Dr David McIntyre (Immediate Past President) david.mcintyre@mater.org.au SECRETARY Dr Aidan McElduff Royal North Shore Hospital St Leonards, NSW Ph (02) Fax (02) aidanmc@bigpond.com TREASURER Dr Glynis Ross Royal Prince Alfred Hospital Camperdown, NSW Ph (02) Fax (02) gpross@bigpond.net.au NEWSLETTER EDITOR Dr Janet Rowan National Women s Health Auckland, NZ Ph Fax jrowan@internet.co.nz AUSTRALIAN CAPITAL TERRITORY Dr Chris Nolan (President) NEW SOUTH WALES Dr Aidan McElduff (Secretary) Dr Glynis Ross (Treasurer) NORTHERN TERRITORY Dr Diane Howard Casuarina, NT Ph Fax (08) dmhoward@physicians-nt.com QUEENSLAND Dr Leonie Callaway Royal Brisbane & Women s Hospital Herston, QLD lcallaway@somc.uq.edu.au Karen Pleash Ipswich and Logan Hospital Ipswich, QLD Ph (07) Fax (07) karenandbrucepleash@bigpond.com SOUTH AUSTRALIA Dr Bill Jeffries Lyell McEwin Health Service Elizabeth Vale, SA Ph (08) Fax (08) Bill.Jeffries@nwahs.sa.gov.au Luisa Pinto luisa.pinto@nwahs.sa.gov.au Toni Willson toni.willson@nwahs.sa.gov.au TASMANIA Dr Anne Duffield Royal Hobart Hospital Hobart, TAS Ph (03) Fax (03) anne.duffield@utas.edu.au VICTORIA Dr Harry Georgiou Mercy Hospital for Women Heidelberg, VIC Ph (03) Fax (03) harrymg@unimelb.edu.au Prof Jeremy Oats Royal Women s Hospital Carlton, VIC Ph (03) Fax (03) jeremy.oats@rwh.org.au Contents ADIPS Executives 2 President's Report 3,4 Editorial Annual Meeting Annual Meeting 9 Research Grant Award 10 Graz Clock Award 11 Database News 12 News from NZ 13 WESTERN AUSTRALIA Dr Dorothy Graham King Edward Memorial Hospital, Centenary Clinic Subiaco, WA Ph (08) Fax (08) dorothygraham@bigpond.com NEW ZEALAND Dr Janet Rowan (Newsletter Editor) Prof David Simmons Waikato District Health Board Hamilton, NZ Ph Ext.7581 Fax simmonsd@waikatodhb.govt.nz 2 Sponsored by Roche Diagnostics

3 PRESIDENT S REPORT This is my last report as ADIPS president. I would like to thank all outgoing council members for their support over the last four years and in particular I would like to acknowledge the great assistance which I have received from Annette Parry as Secretary, Wah Cheung as Treasurer and Trish Cohen as Administrative Officer. A new ADIPS committee has now been elected and the new office bearers are: President Chris Nolan, Secretary Aidan McElduff, Treasurer Glynis Ross. A good deal has been achieved since our last ASM in Darwin. As requested at that meeting, an ADIPS position statement on GDM incorporating the results of the ACHOIS study was prepared and published in the MJA. A commentary on the same issue was also published in ANZJOG, thus hopefully reaching much of our target audience. After a large amount of work followed by extensive editing, the ADIPS guidelines for care of pre-gestational diabetes were also published in the MJA. Particular thanks are due to Aidan McElduff and Wah Cheung for guiding this opus magnus through to publication. EDUCATION The DVD / video Understanding Gestational Diabetes is now in circulation and in demand throughout Australia and New Zealand. This project was funded by Diabetes Australia with ADIPS participation in its content. NDIPAC With prompting from many members, NDiPAC progressed to a face to face meeting in Melbourne on May 25, 2006, with the specific aim of developing a workplan for diabetes in pregnancy issues for This was a most productive day and produced a list of priority areas to be addressed with the aim of improving care for women with diabetes in pregnancy. As yet, there is no clear source of program funding for broad implementation of this workplan, but its mere existence marks significant progress. DATA COLLECTION The national pilot program of data collection covering pregnancies complicated by gestational or pregestational diabetes has been completed and submitted for publication. Revisions / simplifications of the database are progressing and a further round of data collection is planned in the near future. IADPSG IADPSG continues as an umbrella organisation for national diabetes in pregnancy societies around the world. The group is still planning to hold another international meeting, most likely in the USA in early This is likely to run in conjunction with a further GDM workshop, designed to translate the results of the HAPO study into clinical recommendations. ANNUAL MEETING We are very pleased to welcome our overseas invited speaker for the 2006 ASM, Professor Andrew Hattersley and we thank Novo Nordisk for again supporting this important part of the meeting. Thanks also to Peter Davoren for coordinating this meeting and to ASN for their efficient organisation. Dr. David McIntyre August 2006 Australasian Diabetes in Pregnancy Website. Information about the society can be found at: Information about the International Association of the Diabetes and Pregnancy Study Groups can be found at: with links to ADIPS and other regional study groups. Australasian Diabetes in Pregnancy Newsletter. HAVE YOUR SAY! Anyone wishing to contribute an article to the newsletter that is relevant to the mission of ADIPS, please contact the Newsletter Editor, Janet Rowan at jrowan@intermet.co.nz Contributions and ideas are most welcome. Sponsored by Roche Diagnostics 3

4 INCOMING PRESIDENT S REPORT As incoming president, and on behalf of all ADIPS members, I would like to first of all congratulate and thank the outgoing Council for their many achievements over the last 4 years. Standing out in these achievements is the ADIPS guidelines statement for the management of women with pre-existing diabetes in pregnancy, now published in the MJA. The outgoing Executive in David McIntyre as President, Annette Parry as Secretary and Wah Cheung as Treasurer and Harry Georgiou as Newsletter Editor have contributed a great deal to have the Society in its current healthy position. The new Council looks forward to the next 2-4 years. I would like to congratulate in particular Aidan McElduff, Glynis Ross and Janet Rowan on their elections to Secretary, Treasurer and Newsletter Editor in the new Council. Thank you also to Wah Cheung and Harry Georgiou for volunteering to assist in the change over period. I am pleased to announce that the next ADIPS Annual Scientific Meeting will be held in Christchurch, New Zealand on 7-8th Sept 2007, immediately following the combined ADS/ADEA/NZSSD meeting. The meeting should be highly informative with sessions being devoted to the outcomes of the HAPO and MiG clinical trials. Our invited international plenary speaker will be Sylvie Hauguel-DeMouzon from Cleveland, Ohio. Her expertise relates to pathogenesis of diabetic fetopathy including placental metabolism. Dr Christopher Nolan September 2006 ADIPS immediate past-president Dr David McIntyre Incoming-president Dr Chris Nolan 4 Sponsored by Roche Diagnostics

5 EDITORIAL Welcome to the second newsletter for 2006 and to the new ADIPS executive. This issue includes the last report from our out-going President, Dr David McIntyre. Under David s strong leadership the Society has continued to grow and has strengthened its advocacy role in many areas of Diabetic Medicine. I m sure all members will join me in thanking David for his hard work and countless contributions to the Society. His enthusiasm and good humour will be well recognised by those who served on the executive under his leadership. The tremendous contributions of our out-going secretary, Annette Parry; and treasurer, Wah Cheung, must also not go unrecognised. It is the tireless and often thankless work of such members that help create and maintain a vibrant and active Society. Members of the new executive together with their contact details can be found in the newsletter. important educational, medical and scientific information relevant to gestational diabetes. This will also be the last hard-copy version of the newsletter as we go fully electronic into the future. Past and future issues of the newsletter will be available to members from the ADIPS website. I hope members will join me in supporting Janet as she steers the ADIPS newsletter to new heights. Dr Harry Georgiou Outgoing Editor The bulk of this newsletter reports on the recent Annual Scientific Meeting held at the Gold Coast Convention Centre on 25th-26th August. The meeting was very well attended and generously sponsored by Novo-Nordisk Pharmaceuticals, Eli Lilly Australia, Sanofi-Aventis, Abbott Diagnostics and Medtronic Australasia. The scientific content of the meeting was singlehandedly organised by Peter Davoren, who should be thanked and congratulated for another highly successful and informative conference. Those who attended will undoubtedly agree that the meeting highlight were the two inspiring presentations given by our visiting speaker, Prof. Andrew Hattersley from Exeter, U.K. Presentations of the annual Graz Clock Award and the Novo-Nordisk Research Grant Award were also made at the conference. The Society is pleased to announce that the next ASM will be held in Christchurch, NZ and invites all members to attend the conference. This is my last report as editor of the ADIPS newsletter and soon I will pass this important task on to Dr Janet Rowan. I hope members have enjoyed reading the newsletter as much as I have in preparing this informative, prestigious publication. The newsletter serves many roles least of which is the valuable opportunity for members and healthcare workers to publish Sponsored by Roche Diagnostics 5

6 ADIPS ANNUAL SCIENTIFIC MEETING th Gold Coast, August 2006 This year s Annual Scientific Meeting on the Gold Coast completed a week of scientific and medical presentations, posters and lectures that commenced a week earlier with the Endocrine Society s Clinical Weekend. ADIPS welcomed over 100 registrants, some who flew in just for the ADIPS program, others who enjoyed some or all of the week-long extravaganza. Without doubt the highlight of the meeting was the two plenary lectures of our Novo Nordisk visiting lecturer, Professor Andrew Hattersley, Professor of Molecular Medicne at the Peninsula Medical School, Exeter UK. Andrew s first lecture Molecular Genetics Goes to the Diabetes Clinic was a joint plenary session with the Australian Diabetes Society. Andrew described various recognized forms of monogenic diabetes including those associated with mutations in the glucokinase gene, the genes encoding the transcription factors HNF-1α, HNF-1β, HNF-4α along with Insulin Promoter Factor-1 and Neuro- D1. The lecture provided information on recognizing these single gene defect forms of diabetes and implications for treatment. Of note, the form of maturity-onset diabetes of the young (MODY) associated with changes in the glucokinase gene results in a modest and stable elevation in the blood glucose, that is a re-setting or normal blood glucose in affected individuals which shows little deterioration with time (or pregnancy) and is rarely associated with significant diabetes complications. On the other hand those forms of MODY associated with transcription factor abnormalities usually demonstrate a more substantial deterioration in blood glucose control over time but can respond strikingly to sulphonylureas. Of particular interest is the form of diabetes resulting from activating mutations in the gene encoding a subunit of the KATP channel, the Kir6.2 subunit. This form of diabetes classically presents before 6 months of age and as such is usually treated as type 1 diabetes. The importance of recognizing the condition lies in the fact that high dose sulphonylurea therapy can usually control blood glucose better than insulin and usually patients can be removed from insulin therapy. Novo-Nordisk international guest speaker, Prof. Andrew Hattersley from Exeter UK, delivering his address at the 2006 annual scientific meeting. Prof. Hattersley presented two plenary lectures, Molecular genetics goes to the diabetes clinic and Fetal macrosomia in diabetic pregnancy is baby or mother to blame? 6 Sponsored by Roche Diagnostics

7 It is likely that many patients with monogenic forms of diabetes pass through our pregnancy diabetes clinics (although most patients do not have monogenic forms of diabetes) and being alert to the possibility can be of great benefit to the patient if such a condition is recognized. Andrew s second lecture Fetal Macrosomia in Diabetic Pregnancy is Baby or Mother to Blame? reminded us that we should remember that maternal factors, including blood glucose control are not the sole predictors of birthweight. Using examples from pregnancies complicated by monogenic forms of diabetes Andrew demonstrated that fetal genetic factors and paternal influences also contribute to fetal size. In those forms of monogenic diabetes where insulin secretion is reduced, if the fetus is affected then birthweight is reduced (as in glucokinase and the Kir6.2 forms of MODY). If, however, the mother is affected and the baby is not affected the more likely event is a large baby. The first session of free communications included both basic science and health promotion. We heard from Sue Mei Lau a description of a mouse model for diabetic pregnancies. The β-arnt knockout mouse (beta-cell specific aryl hydrocarbon receptor nuclear translocator) demonstrates a diabetes phenotype without the need to introduce beta cell toxins, overfeeding or whole-body knockouts which all provide confounding variables when trying to study diabetes and diabetes in pregnancy in animal models. Harry Georgiou presented his results of using random plasma insulin and adiponectin assays at 11 weeks to predict women who will develop gestational diabetes. Not withstanding the arguments about how GDM should be diagnosed later in pregnancy Harry s data provided further food for thought on how we should be detecting impaired glucose metabolism in pregnancy. The next three presentations all addressed the issue of exercise in GDM. Quite alarmingly, we heard that most pregnant women have little understanding of the benefits of exercise in pregnancy and many women are guided myths and/or cultural expectations to rest whilst pregnant. As few as 30% of pregnant women adhere to exercise advice in pregnancy. Iracema Santos provided some hope describing an evaluation of specific exercise advice being performed in Perth. Friday s late afternoon session started with two presentations from Adelaide and Newcastle on efforts to ensure women who have had GDM receive appropriate follow-up and advice. Katherine Baldock described a recall register as part of a public health initiative in South Australia. After a pilot program demonstrated that around 50% of women were responding to the program, the program is now being rolled out to a larger number of patients by including a large public hospital in the system. Cheryl Watterson from Newcastle explained the postcard program being used to encourage women to attend for follow-up after a pregnancy complicated by GDM. The postcards are branded with the logo of the program however maintaining an accurate mailing list was proving a significant obstacle to the program. The next presentation was in many ways a description of the other end of the spectrum in terms of a blanket approach to public health. Elizabeth Johnson showed the wide variety of approaches to screening for GDM in the Waikato region of New Zealand. Aidan McElduff concluded the presentations for Friday with a data from the New South Wales Midwives Data Collection and In-patients Statistics Collection on pregnancies affected by GDM and pre-gestational diabetes. The rate of pre-gestational diabetes in the study period ( to ) was 0.3% and 4.5% for GDM. Major maternal morbidity or mortality was commonest in pre-gestational diabetes (7.9%), followed by GDM (3.2%) and then those pregnancies not complicated by diabetes (2.7%). For infant morbidity and mortality the rates were 13.7%, 3.5% and 3.1% respectively. Saturday s sessions got underway firstly with Andrew Hattersley s second lecture, then Bob Moses presented the results of a study in which pregnant women (not with GDM) were randomized to receive either a low GI diet or a high GI diet. Those advised on the low GI diet were able to follow it and had smaller babies as a result. Leonie Callaway followed with the results of a survey that suggested women contemplating pregnancy often attempted to lose weight prior to becoming pregnant. She suggested that such women might be Sponsored by Roche Diagnostics 7

8 successfully targeted for weight loss interventions in the future. Kate Gilbert described the results of a survey investigating the effectiveness of the booklet Can I Have a Healthy Baby? Not only did the survey show that those who read the book found it very useful but Kate also announced that funding had been granted to allow the printing and dissemination of the booklet at all women on the NDSS database. Helen Barrettt concluded the session with a study of the relationship between blood glucose levels in the peripartum period and neonatal hypoglycaemia. Helen s data indicated that maternal blood glucose levels in the peripartum period appear to have no impact on the risk of n e o n a t a l hypoglycaemia. Jeff Flack, David McIntyre and David Simmons informed the conference of the progress of the minimum dataset and the pilot of its use along with the development of Action Areas for diabetes in pregnancy should Annual Dinner guests and members enjoying a relaxing evening. ADIPS be swamped with money to initiate programs, research or audits. The session on When to Deliver in Type 1 Diabetes was well received with plenty of comment from the floor. Aidan McElduff presented the best evidence and collective wisdom from the literature and David McIntyre presented a demanding case for discussion. The whys and wherefores of changing insulin requirements in pregnancy were debated and sufficient uncertainty remained to allow this topic to appear on the program some time in the future. Jane Payne showed the increasing prevalence of GDM at Bankstown Hospital over the last six years. The age of women affected is falling, insulin use is increasing despite the use of the same criteria and Caesarean rates are constant at just over 20%. Eileen Sung contributed further to data on the difficulties in following up women who have had GDM, indicating that as few as a third of women in some ethnic groups attend for followup. Bronwyn Sinclair attempted to identify risk factors for large babies by studying maternal factors in the mothers of all large babies born at Auckland City Hospital. Unfortunately attacking the question from this angle did not provide any clear answers. The final presentation from Michele Kwik described the outcome of pregnancies at Royal North Shore Hospital when examined on a treated versus untreated basis according to the diagnostic criteria used in ACHOIS. These outcomes for untreated pregnancies included larger babies and a trend to more shoulder dystocia, low Apgar scores and NICU admission. The meeting had great support from industry this year. As mentioned already Novo Nordisk as our major sponsor made it possible for us to bring out Andrew Hattersley from the UK. We were also pleased and grateful to receive support from Lilly, Sanofi Aventis, Abbot and Medtronic. As we have come to expect Mike Pickford and Christine Baker of ASN did a great job with preconference and in-conference organization. Our first visit to the new Gold Coast Convention Centre was well received and we enjoyed excellent facilities very close to all Broadbeach has to offer. Dr Peter Davoran Local Organising Chair 8 Sponsored by Roche Diagnostics

9 Event of the year!!! ADIPS Annual Scientific Meeting 7 th and 8 th September 2007 Christchurch, New Zealand Put this in your diaries now! HIGHLIGHTS INCLUDE: International Guest Speaker, Sylvie Hauguel-Mouzon Sylvie currently works in Cleveland, Ohio with Pat Catalano. She has a major interest in the pathogenesis of diabetic fetopathy and metabolism of the placenta. She is the Chairperson of the Diabetes in Pregnancy Study Group (DPSG). Jeremy Oats has agreed to talk to us about the Hyperglycaemia and Pregnancy Outcomes (HAPO) trial and its findings. No doubt there will be plenty of discussion around recommended cut off criteria for the diagnosis of GDM. Janet Rowan is hoping to tell us about the Metformin in Gestational Diabetes (MiG) trial and its initial results. This may be the world premiere presentation. The social programme is already being planned. More details are to come, and it may change, but at present all we can say to the men is that the dinner may involve some exposure of parts that are usually under wraps. Just remember the words tartan and knees. Sponsored by Roche Diagnostics 9

10 2005 ADIPS RESEARCH GRANT AWARDA ARD The 2006 ADIPS research grant award was announced at the Annual Scientific Meeting at the Gold Coast in August. The grant is generously sponsored by N o v o - N o r d i s k Pharmaceuticals Pty Ltd and was presented by Ms Line Vang to Jane Payne who accepted on behalf of J Payne, S Dudaee-Faass, GP Ross and JR Flack for the project Post-partum Attitudes and Options for Follow-up of Women with Gestational Diabetes Mellitus. A brief summary of the project is presented below. Post-partum attitudes and options for follow-up of women with Novo-Nordisk representative Ms Line Vang (right) presenting the 2006 Gestational Diabetes Mellitus ADIPS Research Grant (Education) to Jane Payne (left). Gestational Diabetes Mellitus a healthy baby enough to forget about the is increasing in Australia, in our clinic at the Mother s health? From these questions our project Diabetes Centre (Bankstown, NSW) we recently was developed, entitled: Post-partum Attitudes noted an average of 9.6% over last 6 years of our and Options for Follow-up of Women with pregnant population being diagnosed with GDM. Gestational Diabetes Mellitus. With the help of For many years we have maintained a our Clinical Psychologist we hope to answer these comprehensive database regarding all our patients questions and more. We hope to provide some but most especially women with GDM. Our usual tools for education and strategies to support postpartum follow-up in women with GDM. clinical care includes post-partum follow-up 75gm Oral Glucose Tolerance Test at 6-8 weeks. We have noted that certain ethnic groups tend not to return I would like to thank Novo-Nordisk for their to complete their post-partum test, in particular support and assure you all that we are most women from Anglo-Celtic and Arabic background. grateful for the opportunity to research this important health issue. We are hoping to share our I have wondered just why this is. Do the women results with you in understand the importance of getting tested, are we (the Diabetes in Pregnancy team) sending an Jane Payne (Nurse Practitioner) effective message to these women or is just having Bankstown, NSW 10 Sponsored by Roche Diagnostics

11 2006 GRAZ CLOCK AWARDA ARD The Graz Clock Award is presented each year at the ADIPS Annual Scientific Meeting for the best original research and presentation. This year, the award was presented to two people representing Scientific and Educational Research. The winners of the award were: Michele Kwik for her presentation on ACHOIS confirmed: Adverse Perinatal Outcomes in Pregnancies Complicated by Mild Untreated Gestational Diabetes. Michele is from the Perinatal Research Group, Royal North Shore Hospital in St Leonards. Her research associates include S Seebo, C Smith, J Morris and A McElduff. Kate Gilbert, Founder and President of consumer group, Reality Check for her presentation "Evaluating a Consumer Resource about Pregnancy for Women with Pre-existing Diabetes, and Investigating Further Information Needs." Kate presented data from an online survey of 18 health professionals and 70 women with diabetes which found the resource "Can I Have a Healthy Baby?" to be effective and highly valued. The survey also identified further information needs of women to include: quality online information; more details about risks and complications; and a need to better understand the needs of women with pre-existing Type 2 diabetes. Her colleagues in this ongoing project are R Scibilia, J Lagstrom and A Parry. Recipients of the 2006 GRAZ CLOCK Award presented by ADIPS President, Dr Chris Nolan, to Michele Kwik (left panel) and Kate Gilbert (right panel). Sponsored by Roche Diagnostics 11

12 ADIPS PILOT NATIONAL DIABETES IN PREGNANCY CLINICAL AUDIT PROGRAMME REPORT: SEPTEMBER 2006 The team are pleased to announce that the proposal put to the Department of Health and Ageing has been accepted and that Jeff Flack will be able to undertake the benchmarking functions for 12 months for all diabetes in pregnancy clinics across the Society. The funding also includes an upgrade to the software which he is currently working on. The software will be able to serve for stand alone and networked situations. We are also happy for centres to use the screens in their own centre and export to the benchmarking centre from that. The full forms to be used as paper clinical records are now on the website for downloading. This form includes the first visit audit form, outcomes audit form and a sheet for clinical notes. Copies of the ongoing sheets (not part of the audit) that we use are also available from me. A short form will also be available on the website for those wanting to undertake a pure chat review type audit. For a centre number, please contact me and I will provide a unique code to which the benchmarking centre will be blind. Could those interested in joining the next audit round, please me on simmonsd@waikatodhb.govt.nz David Simmons Coordinator, ADIPS audit programme Panel members discussing the National Diabetes in Pregnancy Audit Programme, Prof David Simmons (left panel), Prof Jeff Flack (middle panel) and Dr David McIntyre (right panel) 12 Sponsored by Roche Diagnostics

13 ADIPS NEWS FROM NEW ZEALAND Following the publication of the ACHOIS study, New Zealand members of ADIPS began discussions with the New Zealand College of Midwives to review the current approach to screening for Gestational Diabetes Mellitus (GDM). It was agreed to hold a joint workshop on the 10th March 2006 to discuss an approach to screening for GDM tailored to the special environment in New Zealand, where most normal pregnancies are now managed by midwives. The workshop included presentations by Norma Campbell from the New Zealand College of Midwives as well as David Simmons, Janet Rowan and Peter Moore. Attendance was around 50 from the major professional and consumer organisations involved in pregnancy and diabetes. Four themes emerged from the workshop: Should all women be offered screening for GDM in the New Zealand environment? What should the 2 hour cut off be? How should we screen for undiagnosed Type 2 diabetes in pregnancy? What models of care should there be to deal with the large increase in women with GDM diagnosed should screening uptake be increased and the 2 hour glucose criteria be lowered? It was agreed to hold a further workshop to begin developing a technical report on these questions. This was held on the 1st June 2006 with 18 representatives attending (at least one from each organisation). Four working groups have been established and draft documents have now been created from each group. Progress towards a technical report agreed by the representatives is being made, with a view to distribution within each of the organisations. It is hoped that after further amendment, a position will be achieved which each organisation will be able to sign off for implementation among their members across New Zealand. ADIPS Council will be asked to comment on the document on behalf of its New Zealand members. The process has been co-chaired by Norma Campbell and David Simmons and the 4 working groups chaired by Rosemary Reid (RANZCOG), Janet Rowan (ADIPS), Peter Moore (NZSSD) and Don Simmers (RNZCGP). We would like to thank the working group chairs, ADIPS and New Zealand College of Midwives for their assistance, participating organisations and their representatives, and the New Zealand Ministry of Health for its support. David Simmons, Council Member Christchurch - Venue for the 2007 ADIPS Annual Scientific Meeting Sponsored by Roche Diagnostics 13

14 ADIPS Order Form & Tax Invoice! Can I have a healthy baby? ABN The booklet aims to answer many of the questions facing women with diabetes who are thinking of starting a family, or who have just found out they are pregnant. This information booklet is a combined production by the Australasian Diabetes in Pregnancy Society, Diabetes Australia-Victoria and Reality Check-Young Adults with Diabetes Please tell us what you think of the booklet, so we can improve future prints. ADIPS and DAV have agreed to subsidise half the printing costs to help minimise costs to our consumers. We hope Institutions will uphold the aim and provide this useful resource to women at no charge. An electronic copy of the booklet can be downloaded from the ADIPS webpage at Name: Health Professional / Self Address: State: P/Code: Telephone No: Fax: Please send: c each. Cheque enclosed - made payable to ADIPS Date: Please debit Visa card Mastercard. Credit card No: Expiry date: Name on Card: Signature For orders please fax or post to: ADIPS Secretariat 32 St. Georges Road, Toorak, Victoria 3142 Fax: We value your feedback!

15 The Australasian Diabetes in Pregnancy Society 32 St. Georges Road, Toorak Vic 3142 Phone/Fax: (03) ABN: APPLICATION FOR MEMBERSHIP AUSTRALASIAN DIABETES IN PREGNANCY SOCIETY Name of Applicant: Address: State Post Code Professional Qualifications: Phone No: Bus: Fax: (please print clearly) Nominated: Seconded: Please Note: Nominators and Seconders must be financial Members of ADIPS. If you have no contact with financial members, please notify Secretary Dr Aidan McElduff, Royal North Shore Hospital Pacific Highway, St. Leonards, N.S.W Tel: (02) , Fax (02) , Application form together with Membership Fee of AU$60.00 should be forwarded to: Mrs. Trish Cohen ADIPS 32 St. Georges Road Toorak, VIC 3142, Australia Fax: Cheque: Please make payable to ADIPS Credit Card: Mastercard Visa (other cards not accepted) Card Number: Expiry Date: Name on Card: Signature: Privacy Note: ADIPS complies with National Privacy Legislation, Privacy Amendment (Private Sector) Act 2001, effective 21 December, 2001.

16